Related Experiment Videos
Ground control to Major Tom: "prepare for HIV landing"
1Department of Infectious Diseases, Integrative Virology, University Hospital Heidelberg and German Center for Infection Research, 69120 Heidelberg, Germany; Molecular Medicine Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), 34149 Trieste, Italy.
Cell Host & Microbe
|December 20, 2014
Summary
Natural variations in HIV-1 integrase can alter where the virus integrates its genetic material within host cells. These changes are linked to faster disease progression in patients with HIV-1 infection.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) productive infection depends on integrating viral complementary DNA (cDNA) into the host genome.
- HIV-1 integrase is the enzyme responsible for catalyzing this crucial integration step.
- Understanding integration site selection is key to viral pathogenesis and therapeutic strategies.
Purpose of the Study:
- To investigate the impact of natural HIV-1 integrase polymorphisms on viral cDNA integration.
- To determine if specific integrase variations are associated with altered integration site preferences.
- To explore the relationship between these polymorphisms and the rate of HIV-1 disease progression.
Main Methods:
- Analysis of HIV-1 integrase sequences from patient samples.
- In vitro assays to assess the integration activity of polymorphic integrase variants.
- Next-generation sequencing to map viral integration sites in host genomes.
Main Results:
- Identification of natural HIV-1 integrase polymorphisms.
- Demonstration that these polymorphisms can retarget viral integration away from gene-dense genomic regions.
- Correlation between specific integrase polymorphisms and accelerated disease progression in HIV-1 infected individuals.
Conclusions:
- Natural variations in HIV-1 integrase influence viral integration site selection.
- Retargeting integration away from gene-rich areas by these polymorphisms may impact viral latency and pathogenesis.
- These findings highlight integrase polymorphisms as potential determinants of HIV-1 disease progression and novel therapeutic targets.